Cytosorbents (CTSO) Other Non-Current Liabilities (2014 - 2017)

Cytosorbents (CTSO) has 4 years of Other Non-Current Liabilities data on file, last reported at $1.0 million in Q2 2017.

• For the quarter ending Q2 2017, Other Non-Current Liabilities fell 42.13% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2017 stood at $1.0 million (down 42.13% YoY), and the FY2016 full-year result was $1.8 million, up 10.72% from the prior year.
• Other Non-Current Liabilities for Q2 2017 stood at $1.0 million, down from $1.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.0 million in Q4 2014 and bottomed at $1.0 million in Q2 2017.
• The 4-year median for Other Non-Current Liabilities is $1.7 million (2016), against an average of $1.9 million.
• The widest annual swing landed in 2015, when Other Non-Current Liabilities sank 45.12%; it then rose 10.72% in 2016.
• A 4-year view of Other Non-Current Liabilities shows it stood at $3.0 million in 2014, then tumbled by 45.12% to $1.6 million in 2015, then grew by 10.72% to $1.8 million in 2016, then tumbled by 42.23% to $1.0 million in 2017.
• The last three Other Non-Current Liabilities figures came in at $1.0 million (Q2 2017), $1.7 million (Q1 2017), and $1.8 million (Q4 2016), per Business Quant data.

Peer Comparison